YmAbs Raises $50 Million in Equity Financing 24 October 2017
Y-mAbs Therapeutics, Inc. closes $50 million in a private placement led by HBM Healthcare Investments... Read more
Y-mAbs Therapeutics, Inc. closes $50 million in a private placement led by HBM Healthcare Investments... Read more
For nogle uger siden præsenterede regeringen sit erhvervs- og iværksætterudspil med 22 initiativer... Read more
Oral presentation of efficacy and safety data of Sym004 in refractory metastatic colorectal cancer Symphogen... Read more
Pan-Nordic mentor network NOME provides Nordic life science start-ups with the opportunity to present... Read more
Interesting EU project PERMIDES provides innovation vouchers for biopharma SMEs valued up to 60,000... Read more
Området for Personlig Medicin har potentialet til at blive et vigtigt dansk forskningsområde med lovende... Read more
Mens sommerferien nu er i gang i det meste af Danmark er Udenrigsministeriet aktuelt ved at lægge sidste... Read more
Join Precision NanoSystems for its second annual nanomedicines symposium, entitled Nanomedicines: enabling... Read more
The FDA grants Y-mAbs Therapeutics, Inc. a Rare Pediatric Disease Designation for hu3F8 for the treatment... Read more